Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
Auteurs principaux: | Adam Corey, Nita Johnston |
---|---|
Format: | Article |
Langue: | English |
Publié: |
University of Minnesota Libraries Publishing
2016-12-01
|
Collection: | INNOVATIONS in Pharmacy |
Sujets: | |
Accès en ligne: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
Documents similaires
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
par: Li Y, et autres
Publié: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
par: Mengran Zhang, et autres
Publié: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
par: Li-Qin Jiang, et autres
Publié: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
par: Trigo P, et autres
Publié: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
par: M. Yu. Gilyarov, et autres
Publié: (2010-12-01)